Modified UCN2 peptide treatment improves skeletal muscle mass and function in mouse models of obesity-induced insulin resistanceaursc20dev2025-01-29T08:03:45-05:00

Modified UCN2 peptide treatment improves skeletal muscle mass and function in mouse models of obesity-induced insulin resistance

Author(s): Borg et al.
Year: 2021
DOI: 10.1002/jcsm.12746
PMID: 34342159
Related Products: 807B: in-situ Large Rodent/Small Animal Apparatus,
Research Areas: Muscle Pathology & Wasting
Disease Models: Obesity